Company intelligence / Profile preview

Guangdong Pharmaceutical

Dongguan, Guangdong, China

Ownership: Private
Employees: ~1775
Development stage: Other

Overview

Guangdong Zhongsheng Pharmaceutical has a broad portfolio of commercialized and pipeline drugs spanning traditional Chinese patent medicines and generics, including therapies for cardiovascular, neurovascular, ophthalmology, infectious, and digestive indications. Specific clinical results are not publicly detailed, but the company has received multiple national innovation and growth awards for its product pipeline and R&D strength.

Therapeutic areas: ImmunologyOphthalmologyInfectious DiseasesGastroenterologyPulmonologyCardiovascular
Modalities: Small moleculeTraditional Chinese MedicineBiologic
Industry: Biotech

Partnerships

Business contacts and cooperation with pharmaceutical companies in Europe, United States, Japan, and South Korea

Beyond the preview

Go deeper on Guangdong Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guangdong Pharmaceutical.

Explore the full profile